It’s part of a larger battle between Louisiana officials and big health care companies over prescription drug prices.

CVS unveils AI platform raises 2025 forecast, projecting $400B revenue and improved earnings to enhance consumer healthcare experience.

CVS Health’s stock rose more than 2% on Tuesday after the company boosted its revenue and profit guidance for the year and ...

CVS Health’s narrative has shifted with a slightly higher fair value estimate, nudging from about $91.50 to roughly $92.40 ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

BATON ROUGE, La. (WAFB) - Louisiana has settled two federal lawsuits against CVS Health Corporation and its pharmacy benefit ...

CVS Health shared that it is launching an open consumer engagement platform to simplify care and improve health.

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail ...

CVS Health used its Investor Day on Tuesday as a megaphone for the retailer’s success, raising its full-year financial ...

CNBC’s Jim Cramer sits down with CVS Health CEO David Joyner to discuss the company's investor day, how healthcare technology ...

CVS Health shares climbed Tuesday after the health conglomerate hiked its full-year outlook and outlined plans for a new AI ...